Entero Healthcare Solutions Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2023 • Trading of Pharmaceutical & Surgical Products: 100.0%
AI Sector View
AI GENERATEDConsumer Services
Consumer services have a mixed operating backdrop but strong market sponsorship. Foreign tourist arrivals in India rose 6.0% YoY (2026-06), export of services grew 13.0% YoY (2026-06), and headline tourist arrivals were 584000 (Jun/26), though airport passenger traffic was -2.0% YoY (2026-06). Strong FPI inflow of INR 19847 crore over 3 months to 2026-08-31 supports a Buy stance despite some travel softness.
PROS
- Latest quarter profit grew 72.2% YoY, showing strong momentum
- Company has delivered good sales growth of 29.9% CAGR over last 5 years
- Working capital cycle has improved - days down from 88 to 51
- Company maintains a comfortable, low leverage position
- Company converts assets efficiently - asset turnover of 2.1x
CONS
- Company has a low return on equity of 6.7% over last 3 years
- Company has a low return on capital employed of 9.0%
- Receivables are growing faster than sales - a possible quality concern
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.06x)
- Operating cash flow has been negative in recent years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADANIENT | 3057.10 | 55.59 | 413846.54 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| AEGISLOG | 1353.10 | 37.96 | 47493.81 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| CPPLUS | 3830.15 | 94.94 | 45310.84 | 0.04 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| PREMIERENE | 974.55 | 26.57 | 44239.84 | 0.10 | 471.92 | 53.32 | 2462.59 | 35.25 | 33.72 | 29.03 |
| REDINGTON | 393.65 | 18.09 | 30774.55 | 1.52 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| HONASA | 470.95 | 61.70 | 15354.11 | 0.64 | 90.45 | 118.87 | 755.95 | 27.00 | 20.87 | 14.58 |
| LLOYDSENT | 69.79 | 94.88 | 10653.81 | 0.21 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| SGMART | 751.25 | 76.16 | 9468.39 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 10.43 | 4.49 |
| MMTC | 61.96 | 20.78 | 9294.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 33.46 | -1423.53 |
| ENTERO | 1819.35 | 63.14 | 7918.37 | 0.00 | 52.05 | 72.17 | 1940.50 | 38.23 | 10.93 | 5.00 |
| EBGNG | 683.00 | 54.67 | 7786.99 | 0.00 | 28.93 | 56.21 | 412.46 | 32.08 | 20.58 | 11.97 |
| CELLO | 333.00 | 24.01 | 7510.42 | 0.45 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 899 | 996 | 993 | 1,034 | 1,097 | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,940 | |
| 873 | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,639 | 1,824 | 1,876 | |
| Operating Profit | 26 | 29 | 29 | 29 | 30 | 42 | 50 | 49 | 50 | 62 | 68 | 86 | 64 |
| OPM % | 2.87% | 2.87% | 2.88% | 2.79% | 2.75% | 3.26% | 3.68% | 3.65% | 3.57% | 3.95% | 3.97% | 4.50% | 3.30% |
| 1 | 2 | 2 | 9 | 13 | 11 | 8 | 7 | 6 | 5 | -4 | 4 | 3 | |
| Interest | 14 | 18 | 16 | 17 | 10 | 11 | 10 | 10 | 11 | 12 | 14 | 17 | 21 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 15 | 12 |
| Profit before Tax | 7 | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax % | 6.27% | 23.46% | 16.11% | -56.19% | 24.80% | 25.13% | 25.33% | 15.58% | 16.86% | 17.99% | 16.14% | 22.12% | 22.45% |
| Net Profit | 0 | 0 | 0 | 0 | 21 | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| 1.82 | 1.49 | 1.91 | 5.73 | 4.62 | 5.43 | 5.85 | 5.91 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| 1,780 | 2,522 | 3,300 | 3,922 | 5,096 | 6,591 | 7,128 | |
| 1,758 | 2,498 | 3,236 | 3,810 | 4,924 | 6,325 | 6,848 | |
| Operating Profit | 22 | 24 | 64 | 112 | 172 | 266 | 280 |
| OPM % | 1.21% | 0.97% | 1.94% | 2.85% | 3.37% | 4.03% | 3.93% |
| 4 | 4 | 6 | 14 | 40 | 11 | 8 | |
| Interest | 20 | 29 | 49 | 66 | 42 | 54 | 64 |
| Depreciation | 16 | 20 | 24 | 25 | 31 | 43 | 47 |
| Profit before Tax | -11 | -20 | -4 | 36 | 139 | 179 | 210 |
| Tax % | -41.67% | -48.60% | -201.08% | -11.94% | 22.56% | 18.68% | 20.20% |
| Net Profit | -15 | -29 | -11 | 40 | 107 | 146 | 168 |
| EPS | -5.29 | -9.22 | -0.18 | 8.99 | 21.79 | 26.44 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 30%
- 3 Years:
- 26%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 53%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 4%
- 3 Years:
- 7%
- Last Year:
- 9%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 0 | 4 | 4 | 43 | 44 | 44 | |
| Minority Interest | 2 | 2 | 3 | 3 | 46 | 64 |
| -32 | -62 | -73 | 1,593 | 1,676 | 1,639 | |
| 195 | 343 | 423 | 325 | 376 | 683 | |
| Trade Payables | 97 | 140 | 210 | 230 | 397 | 725 |
| 572 | 699 | 739 | 132 | 148 | 392 | |
| Total Liabilities | 833 | 1,125 | 1,307 | 2,326 | 2,688 | 3,546 |
| 189 | 262 | 268 | 289 | 559 | 958 | |
| Capital Work in Progress | 0 | 1 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 58 | 130 | |
| 244 | 310 | 342 | 421 | 660 | 842 | |
| 0 | 0 | 0 | 615 | 830 | 1,212 | |
| Cash & Bank | 83 | 105 | 107 | 893 | 260 | 162 |
| 318 | 447 | 591 | 107 | 321 | 242 | |
| Total Assets | 833 | 1,125 | 1,307 | 2,326 | 2,688 | 3,546 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| -64 | -24 | -33 | -37 | -77 | 96 | |
| Cash from Investing | -31 | -162 | -49 | -705 | 220 | -303 |
| Cash from Financing | 89 | 211 | 73 | 863 | -74 | 124 |
| -11 | 14 | -21 | 121 | 69 | -83 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-12 - Entero Healthcare Solutions Limited has informed the Exchange about General Updates
2026-08-24 - Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
2026-08-24 - Completion of tenure of Mr. Rajesh Shashikant Dalal
2026-08-19 - Entero Healthcare Solutions Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 19, 2026. Further, the company has submitted the Exchange a copy of Scrutinizers report along with voting results.
2026-08-17 - Entero Healthcare Solutions Limited has informed the Exchange about Transcript
2026-08-10 - Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording on Unaudited Financial Results of the Company for the quarter ended June 30, 2026
2026-08-08 - Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication for Unaudited Financial Results for the quarter ended June 30, 2026
2026-08-07 - Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
2026-08-07 - Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
News
Recent coverage and analyst commentary for ENTERO
Loading news…
AI Stock Analyst
Entero Healthcare Solutions Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account